Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma-Reference-Cited by-同舟云学术

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma

Published:2021-11 Issue: Volume:223 Page:113653
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Rango Enrico^ORCID,D'Antona Lucia,Iovenitti Giulia,Brai Annalaura,Mancini Arianna,Zamperini Claudio,Trivisani Claudia Immacolata^ORCID,Marianelli Stefano,Fallacara Anna Lucia,Molinari Alessio,Cianciusi Annarita,Schenone Silvia,Perrotti Nicola,Dreassi Elena,Botta Maurizio

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference46 articles.

1. Silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold;Ortuso;J. Chem. Inf. Model.,2014

2. SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation;D'Antona;Cell. Physiol. Biochem.,2015

3. SGK1 in human cancer: emerging roles and mechanisms;Sang;Front. Oncol.,2021

4. Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression;Hall;Breast Canc. Res. Treat.,2012

5. Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors;Sommer;Biochem. J.,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

2. Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential;Archiv der Pharmazie;2024-05-16

3. Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity;International Journal of Molecular Sciences;2024-02-19

4. Nanozyme-activating prodrug therapies: A review;Chinese Chemical Letters;2024-02

5. Exploring the Role of ADME for Anticancer Prodrugs;Handbook of Oncobiology: From Basic to Clinical Sciences;2024